Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis

[1]  Philippe P Roux,et al.  Controversies around the function of LARP1 , 2020, RNA biology.

[2]  Min-Jung Kim,et al.  Inhibition of Y Box Binding Protein 1 Suppresses Cell Growth and Motility in Colorectal Cancer , 2019, Molecular Cancer Therapeutics.

[3]  Yvonne Tay,et al.  A comprehensive expression landscape of RNA-binding proteins (RBPs) across 16 human cancer types , 2019, RNA biology.

[4]  Yili Yang,et al.  Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo , 2019, Journal of cellular physiology.

[5]  Jing Wang,et al.  WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..

[6]  A. Rustgi,et al.  IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer. , 2018, Carcinogenesis.

[7]  Matthias W. Hentze,et al.  A brave new world of RNA-binding proteins , 2018, Nature Reviews Molecular Cell Biology.

[8]  M. Eilers,et al.  The MYC mRNA 3′‐UTR couples RNA polymerase II function to glutamine and ribonucleotide levels , 2017, The EMBO journal.

[9]  T. Alain,et al.  La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs , 2017, eLife.

[10]  Huiming Sun,et al.  Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target , 2016, Tumor Biology.

[11]  Sol Katzman,et al.  RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. , 2016, The Journal of clinical investigation.

[12]  Gene W. Yeo,et al.  Robust transcriptome-wide discovery of RNA binding protein binding sites with enhanced CLIP (eCLIP) , 2016, Nature Methods.

[13]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[14]  Sadaf Ghaem-Maghami,et al.  The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer , 2015, Nucleic acids research.

[15]  S. Blagden,et al.  The La-Related Proteins, a Family with Connections to Cancer , 2015, Biomolecules.

[16]  Andrea J. Berman,et al.  The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5′TOP sequence , 2015, Nucleic acids research.

[17]  Masahiro Morita,et al.  La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1)* , 2015, The Journal of Biological Chemistry.

[18]  Ruibing Chen,et al.  C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis. , 2015, Journal of proteome research.

[19]  A E Willis,et al.  LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression , 2014, Oncogene.

[20]  Edward L Huttlin,et al.  Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation , 2014, Genes & development.

[21]  Gene W. Yeo,et al.  Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges , 2013, Nature Structural &Molecular Biology.

[22]  Liang Peng,et al.  LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma , 2013, Journal of Translational Medicine.

[23]  P. Thibault,et al.  A Host YB-1 Ribonucleoprotein Complex Is Hijacked by Hepatitis C Virus for the Control of NS3-Dependent Particle Production , 2013, Journal of Virology.

[24]  A. Rosenwald,et al.  The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival , 2013, Leukemia.

[25]  Yunyu Zhang,et al.  An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis. , 2012, Developmental cell.

[26]  Myriam Gorospe,et al.  MS2-TRAP (MS2-tagged RNA affinity purification): tagging RNA to identify associated miRNAs. , 2012, Methods.

[27]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[28]  Laurence Wurth,et al.  Versatility of RNA-Binding Proteins in Cancer , 2012, Comparative and functional genomics.

[29]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[30]  Peter J. Bickel,et al.  Measuring reproducibility of high-throughput experiments , 2011, 1110.4705.

[31]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[32]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[33]  Matthias Mann,et al.  Unbiased RNA–protein interaction screen by quantitative proteomics , 2009, Proceedings of the National Academy of Sciences.

[34]  J. Deragon,et al.  A comprehensive analysis of the La-motif protein superfamily. , 2009, RNA.

[35]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[36]  Richard A Young,et al.  Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.

[37]  Y. Audic,et al.  Post‐transcriptional regulation in cancer , 2004, Biology of the cell.

[38]  H. Wang,et al.  Expression of Jun family members in human colorectal adenocarcinoma. , 2000, Carcinogenesis.

[39]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Alan R. Saltiel,et al.  Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo , 1999, Nature Medicine.

[41]  R. Herrmann,et al.  Overexpression and amplification of c-myc during progression of human colorectal cancer. , 1996, Oncology.

[42]  H. Hibshoosh,et al.  Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. , 1996, Gastroenterology.

[43]  D. Smith,et al.  Over-expression of the c-myc proto-oncogene in colorectal carcinoma. , 1993, British Journal of Cancer.

[44]  M. Erisman,et al.  Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene , 1985, Molecular and cellular biology.

[45]  E. Kuipers,et al.  Colorectal cancer , 2015, Nature Reviews Disease Primers.

[46]  Hemant K Roy,et al.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. , 2002, Carcinogenesis.

[47]  T. Koch,et al.  Photocross-linking of nucleic acids to associated proteins. , 1997, Critical reviews in biochemistry and molecular biology.